WallStreetZenWallStreetZen

NASDAQ: KRSA
Korsana Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KRSA

Based on 1 analyst offering 12 month price targets for Korsana Biosciences Inc

Min Forecast
$43.00+36.03%
Avg Forecast
$43.00+36.03%
Max Forecast
$43.00+36.03%

Should I buy or sell KRSA stock?

Based on 2 analysts offering ratings for Korsana Biosciences Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KRSA stock forecasts and price targets.

KRSA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-14
lockedlocked$00.00+00.00%2026-09-14

1 of 1

Forecast return on equity

Is KRSA forecast to generate an efficient return?

Company
-11%
Industry
-12.93%
Market
134.06%
KRSA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KRSA forecast to generate an efficient return on assets?

Company
-8.07%
Industry
-16.73%
KRSA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KRSA earnings per share forecast

What is KRSA's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.92
Avg 2 year Forecast
-$0.84

KRSA revenue forecast

What is KRSA's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
KRSA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KRSA revenue growth forecast

How is KRSA forecast to perform vs Biotechnology companies and vs the US market?

Company
-100%
Industry
11.52%
Market
18.69%
KRSA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KRSA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KRSA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRSA$31.61$43.00+36.03%Strong Buy
JSPR$0.63$3.38+433.18%Buy
GTBP$11.63N/AN/A
RADX$2.01$16.00+696.02%Buy
TCRX$0.31$1.00+226.80%Hold
View Top Biotech Stocks

Korsana Biosciences Stock Forecast FAQ

Is Korsana Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: KRSA) stock is to Strong Buy KRSA stock.

Out of 2 analysts, 2 (100%) are recommending KRSA as a Strong Buy, 0 (0%) are recommending KRSA as a Buy, 0 (0%) are recommending KRSA as a Hold, 0 (0%) are recommending KRSA as a Sell, and 0 (0%) are recommending KRSA as a Strong Sell.

If you're new to stock investing, here's how to buy Korsana Biosciences stock.

What is KRSA's earnings growth forecast for 2026-2027?

(NASDAQ: KRSA) Korsana Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 23.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,202.66%.

Korsana Biosciences's earnings in 2026 is -$6,707,000.On average, 3 Wall Street analysts forecast KRSA's earnings for 2026 to be -$613,925, with the lowest KRSA earnings forecast at -$589,850, and the highest KRSA earnings forecast at -$631,982.

In 2027, KRSA is forecast to generate -$559,354 in earnings, with the lowest earnings forecast at -$537,419 and the highest earnings forecast at -$575,806.

What is KRSA's revenue growth forecast for 2026-2027?

(NASDAQ: KRSA) Korsana Biosciences's forecast annual revenue growth rate of -100% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 11.52%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 18.69%.

Korsana Biosciences's revenue in 2026 is $1,900,000.On average, 3 Wall Street analysts forecast KRSA's revenue for 2026 to be $0, with the lowest KRSA revenue forecast at $0, and the highest KRSA revenue forecast at $0.

In 2027, KRSA is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is KRSA's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: KRSA) forecast ROA is -8.07%, which is higher than the forecast US Biotechnology industry average of -16.73%.

What is KRSA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KRSA price target, the average KRSA price target is $43.00, with the highest KRSA stock price forecast at $43.00 and the lowest KRSA stock price forecast at $43.00.

The Wall Street analyst predicted that Korsana Biosciences's share price could reach $43.00 by Sep 14, 2027. The average Korsana Biosciences stock price prediction forecasts a potential upside of 36.03% from the current KRSA share price of $31.61.

What is KRSA's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: KRSA) Korsana Biosciences's current Earnings Per Share (EPS) is -$11.67. On average, analysts forecast that KRSA's EPS will be -$0.92 for 2026, with the lowest EPS forecast at -$0.88, and the highest EPS forecast at -$0.95. In 2027, KRSA's EPS is forecast to hit -$0.84 (min: -$0.80, max: -$0.86).

What is KRSA's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: KRSA) forecast ROE is -11%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.